Biomarkers US 2023

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine.

Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations working in the biomarker industry across multiple therapeutic areas, allowing attendees to gain insights into the latest novel biomarker data and technologies.

Expand your knowledge and discuss future priorities in:

Day One Tracks:

• Biomarkers in Drug Discovery & Translational Sciences
• Biomarkers for Precision Medicine & Diagnostic Development
• Biomarkers for Clinical Development

Day Two Tracks:

• Biomarker Analysis & Emerging Technologies
• Omic Approaches in Precision Medicine and Clinical Development

Meet Key Decision makers representing large pharma & biotech companies:
I-Ming Wang (Director, Translational Oncology, Pfizer)
Matthias Von Herrath (Vice President, Novo Nordisk)
Siddha Kasar (Director, Translational Lead, Takeda Pharmaceuticals)
Sandor Szalma (Global Head of Genetics and Systems Biology, Takeda)
Amanda Klein (Executive Director, Translant Therapeutics Consortium, Critical Path Institute)

Find out more: //www.oxfordglobal.co.uk/biomarkers-series-us/agenda/download-agenda/?utm_source=worldconferencecalendar&utm_medium=eventlisting&utm_campaign=biomarkers&utm_content=biomus2023